Guided Capital Wealth Management LLC Buys Shares of 20,693 Encompass Health Corporation (NYSE:EHC)

Guided Capital Wealth Management LLC bought a new stake in shares of Encompass Health Corporation (NYSE:EHC) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 20,693 shares of the company’s stock, valued at approximately $2,096,000. Encompass Health accounts for 1.8% of Guided Capital Wealth Management LLC’s holdings, making the stock its 17th largest holding.

Several other large investors have also modified their holdings of EHC. Colonial Trust Co SC bought a new stake in shares of Encompass Health during the fourth quarter valued at approximately $29,000. Transce3nd LLC bought a new stake in shares of Encompass Health during the fourth quarter valued at approximately $40,000. CBIZ Investment Advisory Services LLC raised its stake in shares of Encompass Health by 38.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after acquiring an additional 127 shares in the last quarter. Signaturefd LLC raised its stake in shares of Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company’s stock valued at $65,000 after acquiring an additional 125 shares in the last quarter. Finally, C M Bidwell & Associates Ltd. raised its stake in shares of Encompass Health by 73.6% during the fourth quarter. C M Bidwell & Associates Ltd. now owns 750 shares of the company’s stock valued at $69,000 after acquiring an additional 318 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Stephens raised shares of Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 price target for the company in a research note on Thursday, June 5th. Barclays lifted their price target on shares of Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a research note on Friday, April 25th. Royal Bank Of Canada lifted their price target on shares of Encompass Health from $110.00 to $125.00 and gave the company an “outperform” rating in a research note on Monday, April 28th. Truist Financial reissued a “buy” rating and issued a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Finally, Wall Street Zen downgraded shares of Encompass Health from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 6th. Eight equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $127.00.

Encompass Health Stock Performance

Shares of NYSE:EHC opened at $119.87 on Thursday. The company has a market capitalization of $12.08 billion, a price-to-earnings ratio of 24.77, a price-to-earnings-growth ratio of 2.42 and a beta of 0.89. Encompass Health Corporation has a 52 week low of $82.74 and a 52 week high of $123.13. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.81. The firm has a 50 day moving average of $115.12 and a 200 day moving average of $103.74.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The business’s quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.12 earnings per share. On average, sell-side analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date is Tuesday, July 1st. Encompass Health’s payout ratio is presently 14.05%.

Insider Transactions at Encompass Health

In other news, EVP John Patrick Darby sold 10,000 shares of the company’s stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the transaction, the executive vice president now directly owns 79,710 shares of the company’s stock, valued at approximately $9,149,910.90. This represents a 11.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Mark J. Tarr sold 118,384 shares of the company’s stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the transaction, the chief executive officer now directly owns 527,070 shares in the company, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 132,663 shares of company stock valued at $16,034,082. Corporate insiders own 2.00% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.